search
Back to results

Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial

Primary Purpose

Dementia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ESML-EX (Physical Activity Program)
ESML-Social (Social Activity Program)
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dementia focused on measuring Aerobic Exercise, Alzheimer's Disease, Burden and Stress, Caregiving Issues, Quality of Life, Early Stage Memory Loss

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Dementia diagnosis
  • Clinical Dementia Rating Scale score
  • Care Partner agrees to participate with care recipient
  • Care recipient lives in the community or a retirement home
  • Both care partner and recipient speak English

Exclusion Criteria:

  • Significant physical or psychiatric illness in either care partner or care recipient that would prevent participant in a exercise program
  • Planning to move out of study area during the 4 month follow-up period

Sites / Locations

  • UWashington

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

No Intervention

Arm Label

ESML-Exercise (Physical Activity Program)

ESML-SOCIAL (Social Activity Program)

No Intervention

Arm Description

ESML-Exercise consists of four weekly 90-minute classes. Each class includes exercises and a brief discussion of a specific health topic. Classes are carried out in small groups of five to six participant/care partner dyads (10-12 people total), to ensure everyone in the class gets individual attention and that all exercises are done safely using proper form.

ESML-SOCIAL consists of four weekly 90-minute seminars. Each seminar includes discussion of a specific topic, open time for socializing, and a "homework" assignment to be completed prior to the next session. Seminars are carried out in small groups of five to six participant/care partner dyads (10-12 people total), to ensure everyone in the seminar gets individual attention and that everyone has a chance to bring up any concerns.

This arm will receive no intervention during the active treatment period. After the 4 month assessment participants can choose to attend a support group.

Outcomes

Primary Outcome Measures

Change from Baseline in Social Activity at post-treatment (1 month)
The Pleasant Events Schedule-AD, long version, will be used to evaluate social participation and activity.
Change from Baseline in Physical Activity at post-treatment (1 month)
The Physical Activity Scale for the Elderly (PASE) will be used to assess level of physical activity of participants and care partners.
Change from Baseline in Quality of Life at post-treatment (1 month)
The Quality of Life-AD (QOL-AD)scale will measure quality of life domains identified as important for cognitively impaired older adults.
Change from Baseline in Social Activity at 4 month follow-up
The Pleasant Events Schedule-AD, long version, will be used to evaluate social participation and activity.
Change from Baseline in Physical Activity at 4 month follow-up
The Physical Activity Scale for the Elderly (PASE) will be used to assess level of physical activity of participants and care partners.
Change from Baseline in Quality of Life at 4 month follow-up
The Quality of Life-AD (QOL-AD)scale will measure quality of life domains identified as important for cognitively impaired older adults.

Secondary Outcome Measures

Change from Baseline in Communication at post-treatment (1 month)
The Communication, Affective Expression, and Involvement subscales of the Family Assessment Measure will measure the quality of caregiver-patient communication.
Change from Baseline in Physical Function at post-treatment (1 month)
The Physical Functioning Scale rates the performance of everyday tasks such as walking around the residence and getting in and out of bed.
Change from Baseline in Mood at post-treatment (1 month)
The Geriatric Depression Scale will assess the mood of the participant and their caregiver.
Change from Baseline in Communication at post-treatment (1 month)
The Communication, Affective Expression, and Involvement subscales of the Family Assessment Measure will measure the quality of caregiver-patient communication.
Change from Baseline in Physical Functioning at post-treatment (1 month)
The Physical Functioning Scale rates the performance of everyday tasks such as walking around the residence and getting in and out of bed.
Change from Baseline in Mood at 4 month follow-up.
The Geriatric Depression Scale will assess the mood of the participant and their caregiver.

Full Information

First Posted
March 5, 2012
Last Updated
June 8, 2015
Sponsor
University of Washington
search

1. Study Identification

Unique Protocol Identification Number
NCT01550718
Brief Title
Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial
Official Title
Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2015
Overall Recruitment Status
Completed
Study Start Date
February 2012 (undefined)
Primary Completion Date
February 2015 (Actual)
Study Completion Date
February 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Alzheimer's disease (AD) is increasing exponentially, with a projected quadrupling of cases by the mid 21st century. Individuals with AD are at increased risk for a host of medical and psychiatric conditions, and evidence is accumulating supporting the efficacy and effectiveness of psychosocial interventions for improving their mood, function, health, and quality of life. Such interventions are likely to be most effective when they are implemented during the early stages of dementia, when individuals and their family members are coping with the initial diagnosis and associated changes in abilities and activities. Recent randomized clinical trials by the Principal Investigator and colleagues have developed two non-pharmacologic interventions to reduce the social, psychological, physical, and behavioral impact of dementia. This investigation is focused on facilitating their translation into ongoing community-based programs, such as those provided by Alzheimer's Association chapters, senior centers, retirement homes, and other health care providers. The core content of each intervention has been retained in order to maintain or improve their efficacy, and each has been modified to a 4-week group format to increase efficiency of delivery. These modified interventions (ESML-Social and ESML-Ex) will be compared to each other and to a usual care (UC) control group. Outcomes will be assessed at baseline, 1-month post treatment, and 4 month follow-up. Primary outcomes at the 1-month assessment include: social activity participation, family communication, physical activity participation, and physical function. Primary outcomes at 4-month follow up include overall quality of life and depression. It is hypothesized that ESML-Ex and ESML-Social both will have greater improvements than UC. It is hypothesized that ESML-Social will have greater improvements in social participation and family communication than ESML-Ex and UC. It is hypothesized that ESML-Ex will have greater improvements in physical activity participation and physical functioning than ESML-Social and UC. If successful, these 4-week programs may be developed into "modules" that can be incorporated into programming for individuals with early stage dementia in a variety of community settings.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dementia
Keywords
Aerobic Exercise, Alzheimer's Disease, Burden and Stress, Caregiving Issues, Quality of Life, Early Stage Memory Loss

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
152 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ESML-Exercise (Physical Activity Program)
Arm Type
Active Comparator
Arm Description
ESML-Exercise consists of four weekly 90-minute classes. Each class includes exercises and a brief discussion of a specific health topic. Classes are carried out in small groups of five to six participant/care partner dyads (10-12 people total), to ensure everyone in the class gets individual attention and that all exercises are done safely using proper form.
Arm Title
ESML-SOCIAL (Social Activity Program)
Arm Type
Active Comparator
Arm Description
ESML-SOCIAL consists of four weekly 90-minute seminars. Each seminar includes discussion of a specific topic, open time for socializing, and a "homework" assignment to be completed prior to the next session. Seminars are carried out in small groups of five to six participant/care partner dyads (10-12 people total), to ensure everyone in the seminar gets individual attention and that everyone has a chance to bring up any concerns.
Arm Title
No Intervention
Arm Type
No Intervention
Arm Description
This arm will receive no intervention during the active treatment period. After the 4 month assessment participants can choose to attend a support group.
Intervention Type
Behavioral
Intervention Name(s)
ESML-EX (Physical Activity Program)
Intervention Description
ESML-EX consists of four weekly 90-minute classes. Each class includes exercises and a brief discussion of a specific health topic.
Intervention Type
Behavioral
Intervention Name(s)
ESML-Social (Social Activity Program)
Intervention Description
ESML-SOCIAL consists of four weekly 90-minute seminars. Each seminar includes discussion of a specific topic, open time for socializing, and a "homework" assignment to be completed prior to the next session.
Primary Outcome Measure Information:
Title
Change from Baseline in Social Activity at post-treatment (1 month)
Description
The Pleasant Events Schedule-AD, long version, will be used to evaluate social participation and activity.
Time Frame
Baseline and post treatment (1 month)
Title
Change from Baseline in Physical Activity at post-treatment (1 month)
Description
The Physical Activity Scale for the Elderly (PASE) will be used to assess level of physical activity of participants and care partners.
Time Frame
Baseline and post-treatment (1 month)
Title
Change from Baseline in Quality of Life at post-treatment (1 month)
Description
The Quality of Life-AD (QOL-AD)scale will measure quality of life domains identified as important for cognitively impaired older adults.
Time Frame
Baseline and post treatment (1 month)
Title
Change from Baseline in Social Activity at 4 month follow-up
Description
The Pleasant Events Schedule-AD, long version, will be used to evaluate social participation and activity.
Time Frame
Baseline and 4 month follow-up
Title
Change from Baseline in Physical Activity at 4 month follow-up
Description
The Physical Activity Scale for the Elderly (PASE) will be used to assess level of physical activity of participants and care partners.
Time Frame
Baseline and 4 month follow-up
Title
Change from Baseline in Quality of Life at 4 month follow-up
Description
The Quality of Life-AD (QOL-AD)scale will measure quality of life domains identified as important for cognitively impaired older adults.
Time Frame
Baseline and 4 month follow-up
Secondary Outcome Measure Information:
Title
Change from Baseline in Communication at post-treatment (1 month)
Description
The Communication, Affective Expression, and Involvement subscales of the Family Assessment Measure will measure the quality of caregiver-patient communication.
Time Frame
Baseline and post treatment (1 month)
Title
Change from Baseline in Physical Function at post-treatment (1 month)
Description
The Physical Functioning Scale rates the performance of everyday tasks such as walking around the residence and getting in and out of bed.
Time Frame
Baseline and post treatment (1 month)
Title
Change from Baseline in Mood at post-treatment (1 month)
Description
The Geriatric Depression Scale will assess the mood of the participant and their caregiver.
Time Frame
Baseline and post-treatment (1 month)
Title
Change from Baseline in Communication at post-treatment (1 month)
Description
The Communication, Affective Expression, and Involvement subscales of the Family Assessment Measure will measure the quality of caregiver-patient communication.
Time Frame
Baseline and post-treatment (1 month)
Title
Change from Baseline in Physical Functioning at post-treatment (1 month)
Description
The Physical Functioning Scale rates the performance of everyday tasks such as walking around the residence and getting in and out of bed.
Time Frame
Baseline and post-treatment (1 month)
Title
Change from Baseline in Mood at 4 month follow-up.
Description
The Geriatric Depression Scale will assess the mood of the participant and their caregiver.
Time Frame
Baseline and 4 month follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Dementia diagnosis Clinical Dementia Rating Scale score Care Partner agrees to participate with care recipient Care recipient lives in the community or a retirement home Both care partner and recipient speak English Exclusion Criteria: Significant physical or psychiatric illness in either care partner or care recipient that would prevent participant in a exercise program Planning to move out of study area during the 4 month follow-up period
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rebecca G Logsdon, Ph.D.
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
UWashington
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial

We'll reach out to this number within 24 hrs